A Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VEL-101
Clinical trial NCT05238493 · COMPLETED
Trial details
- NCT number
- NCT05238493
- Sponsor
- Veloxis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2023-01-03
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.